The Bihar Post

Expert panel clears Oxford-AstraZeneca’s COVID-19 vaccine for emergency use

By Bihar Post Desk Last updated Jan 1, 2021

covid-19, covid vaccines, vaccination fraud, Bihar, gaya — Representational image

Image courtesy: Pexels

NEW DELHI—In a significant development, the Subject Expert Committee of the Central Drug Standard Control Organisation on Friday recommended emergency use of Oxford-AstraZeneca’s ‘Covishield’ vaccine.

You May Like this also

Hoping for last-minute…

Bihar Post Desk

Nitish Kumar not in race for the…

Bihar Post Desk

Prev Next

News agency IANS reported that the application would be sent to Drugs Controller General of India (DCGI) VG Somani for final approval.

- Sponsored -

COVID-19 has claimed 149,018 lives in India, besides infecting 10.3 million people so far. Indian government claims enforcement of early nationwide lockdown has managed to check the spread of coronavirus.

Get real time updates directly on you device, subscribe now.

Bihar Post Desk 6724 posts 0 comments

The Bihar Post aims to provide quick information to our readers but with accuracy. It will also serve as a guide to quality stories. Our utmost effort will be to put the stories in the right perspective without being biased towards any side.

NHRC issues notices to authorities over stranded Indian seafarers in Chinese waters

COVID-19 vaccination can start any time in Bihar, says health minister

Comments are closed.